Anterix Inc.
ATEX
$25.23
$0.150.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.03M | 5.90M | 5.61M | 5.11M | 4.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.03M | 5.90M | 5.61M | 5.11M | 4.19M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 6.03M | 5.90M | 5.61M | 5.11M | 4.19M |
| SG&A Expenses | 48.78M | 49.29M | 51.41M | 51.87M | 50.12M |
| Depreciation & Amortization | 548.00K | 663.00K | 719.00K | 777.00K | 844.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.06M | 56.84M | 59.13M | 59.02M | 56.66M |
| Operating Income | -49.03M | -50.94M | -53.53M | -53.92M | -52.47M |
| Income Before Tax | -9.48M | -28.90M | -34.71M | -19.46M | -7.52M |
| Income Tax Expenses | 1.89M | 1.09M | 2.66M | 3.08M | 1.61M |
| Earnings from Continuing Operations | -11.37 | -29.99 | -37.37 | -22.53 | -9.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.37M | -29.99M | -37.37M | -22.53M | -9.13M |
| EBIT | -49.03M | -50.94M | -53.53M | -53.92M | -52.47M |
| EBITDA | -48.49M | -50.28M | -52.81M | -53.14M | -51.62M |
| EPS Basic | -0.62 | -1.62 | -2.02 | -1.22 | -0.49 |
| Normalized Basic EPS | -1.58 | -1.63 | -1.70 | -1.71 | -1.66 |
| EPS Diluted | -0.63 | -1.63 | -2.02 | -1.22 | -0.49 |
| Normalized Diluted EPS | -1.57 | -1.62 | -1.70 | -1.70 | -1.65 |
| Average Basic Shares Outstanding | 74.26M | 74.17M | 74.26M | 74.60M | 75.06M |
| Average Diluted Shares Outstanding | 74.57M | 74.34M | 74.47M | 75.00M | 75.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |